Financhill
Sell
31

FOLD Quote, Financials, Valuation and Earnings

Last price:
$6.02
Seasonality move :
23.08%
Day range:
$6.09 - $6.31
52-week range:
$5.82 - $12.65
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.49x
P/B ratio:
9.88x
Volume:
6.7M
Avg. volume:
4.9M
1-year change:
-32.72%
Market cap:
$1.9B
Revenue:
$528.3M
EPS (TTM):
-$0.09

Amicus Therapeutics SEC Filings

Company Filed Form Type Description
FOLD
Amicus Therapeutics
05/09/2024 10-Q 10-Q filing on 05/09/2024 View Form
FOLD
Amicus Therapeutics
11/08/2023 10-Q 10-Q filing on 11/08/2023 View Form
FOLD
Amicus Therapeutics
08/08/2023 10-Q 10-Q filing on 08/08/2023 View Form
FOLD
Amicus Therapeutics
05/10/2023 10-Q 10-Q filing on 05/10/2023 View Form
FOLD
Amicus Therapeutics
11/07/2022 10-Q 10-Q filing on 11/07/2022 View Form
FOLD
Amicus Therapeutics
08/04/2022 10-Q 10-Q filing on 08/04/2022 View Form
FOLD
Amicus Therapeutics
05/10/2022 10-Q 10-Q filing on 05/10/2022 View Form
FOLD
Amicus Therapeutics
11/09/2021 10-Q 10-Q filing on 11/09/2021 View Form
FOLD
Amicus Therapeutics
08/05/2021 10-Q 10-Q filing on 08/05/2021 View Form
FOLD
Amicus Therapeutics
05/10/2021 10-Q 10-Q filing on 05/10/2021 View Form
FOLD
Amicus Therapeutics
11/05/2020 10-Q 10-Q filing on 11/05/2020 View Form
FOLD
Amicus Therapeutics
08/10/2020 10-Q 10-Q filing on 08/10/2020 View Form
FOLD
Amicus Therapeutics
05/07/2020 10-Q 10-Q filing on 05/07/2020 View Form
FOLD
Amicus Therapeutics
03/02/2020 10-K 10-K filing on 03/02/2020 View Form
FOLD
Amicus Therapeutics
11/12/2019 10-Q 10-Q filing on 11/12/2019 View Form
FOLD
Amicus Therapeutics
08/08/2019 10-Q 10-Q filing on 08/08/2019 View Form
FOLD
Amicus Therapeutics
05/09/2019 10-Q 10-Q filing on 05/09/2019 View Form
FOLD
Amicus Therapeutics
02/28/2019 10-K 10-K filing on 02/28/2019 View Form
FOLD
Amicus Therapeutics
11/05/2018 10-Q 10-Q filing on 11/05/2018 View Form
FOLD
Amicus Therapeutics
08/07/2018 10-Q 10-Q filing on 08/07/2018 View Form
FOLD
Amicus Therapeutics
05/09/2018 10-Q 10-Q filing on 05/09/2018 View Form
FOLD
Amicus Therapeutics
03/01/2018 10-K 10-K filing on 03/01/2018 View Form
FOLD
Amicus Therapeutics
11/08/2017 10-Q 10-Q filing on 11/08/2017 View Form
FOLD
Amicus Therapeutics
08/07/2017 10-Q 10-Q filing on 08/07/2017 View Form
FOLD
Amicus Therapeutics
05/09/2017 10-Q 10-Q filing on 05/09/2017 View Form
FOLD
Amicus Therapeutics
03/03/2017 10-K 10-K filing on 03/03/2017 View Form
FOLD
Amicus Therapeutics
03/01/2017 10-K 10-K filing on 03/01/2017 View Form
FOLD
Amicus Therapeutics
11/07/2016 10-Q 10-Q filing on 11/07/2016 View Form
FOLD
Amicus Therapeutics
08/09/2016 10-Q 10-Q filing on 08/09/2016 View Form
FOLD
Amicus Therapeutics
05/03/2016 10-Q 10-Q filing on 05/03/2016 View Form
FOLD
Amicus Therapeutics
02/29/2016 10-K 10-K filing on 02/29/2016 View Form
FOLD
Amicus Therapeutics
11/04/2015 10-Q 10-Q filing on 11/04/2015 View Form
FOLD
Amicus Therapeutics
08/05/2015 10-Q 10-Q filing on 08/05/2015 View Form

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

What Stocks Are Recession-Proof?
What Stocks Are Recession-Proof?

Fears of a recession prevailed in Q2 2025 when the…

Which Stocks Are Recession-Proof?
Which Stocks Are Recession-Proof?

Fears of a recession prevailed in Q2 2025 when the…

Is Gartner a Safe Stock to Own?
Is Gartner a Safe Stock to Own?

Gartner (NYSE:IT) is among the world’s largest consulting, research and…

Stock Ideas

Buy
72
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 38x

Sell
48
Is AAPL Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 35x

Buy
70
Is NVDA Stock a Buy?

Market Cap: $3T
P/E Ratio: 42x

Alerts

Buy
64
RGC alert for May 13

Regencell Bioscience Holdings [RGC] is down 31.81% over the past day.

Buy
82
NRG alert for May 13

NRG Energy [NRG] is up 4.09% over the past day.

Sell
44
GDXU alert for May 13

MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is up 0.05% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock